Friday, April 19, 2024

Zoetis announces retirement and appoints new president of R&D

Must read

PARSIPPANY, N.J. — Zoetis Inc. has announced the appointment of Dr. Robert J. Polzer as executive vice president and president of research & development for the company, effective Jan. 1, 2022. Polzer currently serves as senior vice president of global therapeutics for Zoetis and joined the company in 2015 after spending more than 20 years in R&D leadership roles at Pfizer. Polzer will become a member of the Zoetis executive team and report to CEO Kristin Peck.

Polzer will succeed current EVP and president of R&D, Dr. Catherine Knupp, who will remain head of R&. . .

Register or Login to keep reading

Thank you for your interest in accessing the complete content. To continue reading, please register for free. By registering, you'll gain full access to our valuable resources, updates, and insights.

If you already have an account please Log In.

More articles

Latest article